Why Ultrasound Is a Better Alternative to Mammograms for Women with Dense Breasts: Understanding the Federal Mandate on Density Letters
Under a federal mandate passed in 2019, women in the U.S. are now required as of Sept ‘24 to be notified if they have dense breast tissue following their mammogram. The Breast Density Notification Act helps raise awareness about how dense tissue can make it harder for mammograms to detect tumors. While this law helps inform women, it also highlights the need for better screening options, such as ultrasound, especially for women with dense breasts.
The density letter explains that dense breast tissue can obscure tumors, making it harder for mammograms to spot cancer. The letter encourages women to talk to their healthcare provider about additional screening options. While informative, this letter does not offer a solution. That's where ultrasound becomes a valuable alternative.
Eve Wellness stands out by using advanced technologies like the GE Invenia ABUS, an automated 3D breast ultrasound system that offers high-quality imaging for detecting cancers in dense breasts. Learn more about this cutting-edge technology here.
Additionally, Eve Wellness uses AI technology to enhance breast cancer screening. Find out more about how artificial intelligence improves detection here.
The federal mandate to send density letters educates women about the limitations of mammograms for detecting cancer in dense breast tissue. However, ultrasound provides a superior alternative by offering better tumor detection, no radiation exposure, and earlier identification of cancers. If you’ve received a density letter, talk to your healthcare provider about whether an ultrasound might be a better screening option.
Learn more about breast cancer screening with ultrasound: